Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Company's officials will be attending an Investor Conference, organized by Motilal Oswal in Delhi on 16th December, 2022. Kindly take the above on record.
15-12-2022
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the representatives of the following Analyst/ Investors are scheduled to visit our Gurugram Facility i.e. 'Medanta - The Medicity' today dated 12th December, 2022: S. No. Analyst/Investor Firm Name 1. Analyst Ambit Capital 2. Investor Canara Robecco 3. Investor Kotak Mutual Fund 4. Investor Alchemy 5. Investor Habrok Capital Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat.
12-12-2022
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that an one to one Investor Meeting with Perpetuity Ventures has been scheduled in person on Wednesday, 7th December, 2022. Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat.
05-12-2022
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that an one to one Investor Meeting with Vineet Mitera and Anubhav Kaul, the representatives of Ward Ferry has been scheduled in person on Thursday, 1st December, 2022 at 11:30 AM. Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Kindly take the above on record.
29-11-2022
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that following Analyst / Institutional Investors Meetings are scheduled: 1. Friday, 2nd December, 2022- DAM Capital Advisors, One to One Meeting (In Person) 2. Tuesday , 6th December, 2022 - Nuvama Group (Edelweiss), One to One Meeting (In Person) Please note that, no Unpublished Price Sensitive Information are proposed to be shared, thereat. Kindly take the above on record.
29-11-2022
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that an one to one Investor Meeting with the representatives of ASK Investment has been scheduled in person on 28th November, 2022. Please note that, no Unpublished Price Sensitive Information (UPSI) is proposed to be shared, thereat. Kindly take the above on record.
28-11-2022
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that an one to one Investor Meeting with the representatives of 'JM Financial Family Office' has been scheduled virtually at 4 P.M. on 22nd November, 2022. Please note that, no Unpublished Price Sensitive Information (UPSI) is proposed to be shared, thereat.
21-11-2022
Bigul

Global Health Ltd - 543654 - Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information

Dear Sir, Pursuant to Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 ("PIT Regulations") as amended, from time to time, please find enclosed herewith Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information ("UPSI"). Kindly take the same on record.
17-11-2022
Bigul

Global Health Ltd - 543654 - Details Of Key Managerial Personnel Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Of Global Health Limited ("The Company")

Dear Sir, It is hereby advised that, pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Chairman & Managing Director and /or Group Chief Executive Officer, in consultation with Group Chief Financial Officer, Company Secretary and General Counsel of the Company, as the case may be, are authorized to determine the materiality of any event or information and for the purpose of making disclosure to Stock Exchanges.
17-11-2022
Bigul

Global Health Ltd - 543654 - Listing of equity shares of Global Health Ltd

Trading Members of the Exchange are hereby informed that effective from November 16, 2022, the equity shares of Global Health Ltd (Scrip Code: 543654) are listed and admitted to dealings on the Exchange in the list of ''B'' Group Securities. For further details please refer to the notice no 20221115-43 dated November 15, 2022.
16-11-2022
Close

Let's Open Free Demat Account